STOCK TITAN

Borealis Foods (Nasdaq: BRLS) faces Nasdaq warning on late reports

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Borealis Foods Inc. has received a Nasdaq deficiency notice because it has not yet filed its 2025 Form 10-K and its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026. This means the company is currently out of compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely SEC filings.

The notice does not immediately affect trading of Borealis’s common shares or warrants on the Nasdaq Capital Market. The company has until June 16, 2026 to submit a plan of compliance, and Nasdaq may allow up to October 12, 2026 to regain compliance if the plan is accepted. Borealis expects to file the delayed Form 10-Q by early June 2026 and believes that, together with the 2025 Form 10-K, this will resolve the issue.

Positive

  • None.

Negative

  • Borealis Foods is noncompliant with Nasdaq Listing Rule 5250(c)(1) because it has not timely filed its 2025 Form 10-K and Q1 2026 Form 10-Q, creating a near-term listing-compliance risk.
  • The company faces a regulatory deadline of June 16, 2026 to submit a compliance plan to Nasdaq, with potential listing consequences if the plan is not accepted or filings are further delayed.

Insights

Nasdaq noncompliance notice adds listing-risk overhang until filings are cured.

Borealis Foods is now formally noncompliant with Nasdaq Listing Rule 5250(c)(1) due to delayed 2025 Form 10-K and Q1 2026 Form 10-Q. While there is no immediate trading impact, continued delay could ultimately jeopardize the Nasdaq listing if not remedied.

The company has until June 16, 2026 to submit a compliance plan and, if accepted, up to October 12, 2026 to regain compliance. Management states it expects to file the Q1 2026 Form 10-Q by early June, which, together with the 2025 Form 10-K, is expected to cure the deficiency.

The situation introduces governance and execution risk around timely financial reporting and reliance on Nasdaq’s acceptance of the company’s plan. Subsequent SEC filings confirming the actual submission and acceptance of the plan, and the filing dates of the missing reports, will clarify how quickly this risk is reduced.

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities
The company received a delisting notice or transferred its listing to a different exchange.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Notice date May 21, 2026 Nasdaq deficiency notice for late Q1 2026 Form 10-Q
Compliance plan deadline June 16, 2026 Deadline to submit plan of compliance to Nasdaq
Potential cure deadline October 12, 2026 Latest date Nasdaq may allow to regain compliance
Delayed filings 2025 Form 10-K and Q1 2026 Form 10-Q SEC periodic reports not filed on time
Listing venues Nasdaq Capital Market (BRLS, BRLSW) Common shares and warrants listing
Press release date May 27, 2026 Public disclosure of Nasdaq notice
Nasdaq Listing Rule 5250(c)(1) regulatory
"the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1)"
Nasdaq Listing Rule 5250(c)(1) requires companies listed on the Nasdaq stock exchange to promptly notify the exchange if their stock price falls below a certain minimum level, known as the "initial listing standards." This rule helps ensure that investors are aware of significant declines in a company's stock value, which could signal financial trouble or increased risk. Essentially, it helps maintain transparency and protect investors by keeping them informed about important changes in a company's stock performance.
plan of compliance regulatory
"the Company has until June 16, 2026 to submit a plan of compliance to Nasdaq"
A plan of compliance is a formal roadmap a company creates to fix regulatory or legal problems, listing the steps, timelines and responsible parties needed to meet official rules. Investors care because it indicates how quickly and effectively a company can stop penalties, restore trust and return to normal operations—much like a repair plan for a house that shows when rooms will be fixed and how much it will cost.
continued listing requirements regulatory
"the Company's ability to regain and maintain compliance with Nasdaq's continued listing requirements"
Rules a stock exchange sets that a publicly traded company must keep meeting to stay listed and tradable on that exchange, such as minimum share price, market value, timely financial reports, and basic governance practices. Like a club’s membership rules, they matter because falling short can lead to warnings, penalties or removal from the exchange, which can cut liquidity, hurt share value and increase the risk for investors.
forward-looking statements regulatory
"This press release contains forward-looking statements within the meaning of Section 27A"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
Initial Delinquent Filing regulatory
"as designated by Nasdaq, the “Initial Delinquent Filing”"
false 0001852973 A6 0001852973 2026-05-21 2026-05-21 0001852973 BRLS:CommonSharesMember 2026-05-21 2026-05-21 0001852973 BRLS:WarrantsMember 2026-05-21 2026-05-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

May 21, 2026

Date of Report (date of earliest event reported)

 

BOREALIS FOODS INC.

(Exact name of registrant as specified in its charter)

 

Ontario   001-40778   98-1638988
(State or other jurisdiction of
incorporation or organization)
  (Commission File Number)   (I.R.S. Employer
Identification Number)

 

1540 Cornwall Rd., Suite 104
Oakville, ON L6J 7W5

(Address of principal executive offices and zip code)

 

(905) 278-2200

(Registrant's telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol   Name of each exchange on which registered
Common Shares   BRLS   Nasdaq Capital Market
Warrants   BRLSW   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

In connection with the Company's delayed Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2026 (the “Q12026 Form 10-Q”), the Company received, on May 21, 2026, a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the Company has not yet filed the Q12026 Form 10-Q, the Company no longer complies with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires companies with securities listed on Nasdaq to timely file all required periodic reports with the Securities and Exchange Commission. The Notice has no immediate effect on the listing or trading of the Company's Common Shares or Warrants on the Nasdaq Capital Market.

 

The Notice supplements the prior notice received by the Company from Nasdaq on April 17, 2026 (the “Prior Notice”) relating to the Company's delayed Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “2025 Form 10-K” and, as designated by Nasdaq, the “Initial Delinquent Filing”), as previously disclosed by the Company in its Current Report on Form 8-K filed with the SEC on April 23, 2026.

 

In accordance with Nasdaq's listing rules, the Company has until June 16, 2026 to submit a plan of compliance to Nasdaq addressing how the Company intends to regain compliance with the Listing Rule with respect to both the 2025 Form 10-K and Q12026 Form 10-Q. If Nasdaq accepts the Company's plan, Nasdaq may grant the Company up to 180 calendar days from the due date of the Initial Delinquent Filing, or until October 12, 2026, to regain compliance. The Company intends to file the Q12026 Form 10-Q as soon as practicable but anticipates no later than early June 2026, which the Company believes will, together with the filing of the 2025 Form 10-K, cure the deficiency and regain compliance with the Listing Rule.

 

Item 7.01. Regulation FD Disclosure.

 

On May 27, 2026, the Company issued a press release disclosing the receipt of the Notice. A copy of the press release is being furnished herewith as Exhibit 99.1.

 

The information furnished in this Item 7.01 and Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

Cautionary Note Regarding Forward-Looking Statements

 

This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, but are not limited to, statements regarding the Company's anticipated timing for filing the Q1-2026 Form 10-Q and the Company's ability to regain compliance with Nasdaq's listing rules. Forward-looking statements are generally identified by words such as “anticipates,” “believes,” “expects,” “intends,” “plans,” “will” and similar expressions. These statements are based on the Company's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements, including risks related to the completion of the Company's interim financial statements and related interim review, the Company's ability to file the Q12026 Form 10-Q within the anticipated timeframe, the Company's ability to regain and maintain compliance with Nasdaq's continued listing requirements, and other risks and uncertainties described in the Company's filings with the Securities and Exchange Commission. The Company's filings with the SEC are available at www.sec.gov. Investors should not place undue reliance on the Company's forward-looking statements. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of this report, except as required by applicable law.

 

Item 9.01 Financial Statements and Exhibits

 

(d): The following exhibits are being filed herewith:

 

Exhibit No.   Description
99.1   Press Release dated May 27, 2026
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 27 day of May 2026.

 

  BOREALIS FOODS INC.
     
  By: /s/ Pouneh Rahimi
Date: May 27, 2026   Pouneh V. Rahimi
    Chief Legal Officer

 

2

 

Exhibit 99.1

 

BOREALIS FOODS INC. RECEIVES EXPECTED NOTIFICATION OF DEFICIENCY FROM NASDAQ RELATED TO DELAYED FILING OF QUARTERLY REPORT ON FORM 10-Q FOR FISCAL QUARTER ENDED MARCH 31, 2026

 

Toronto, Ontario, May 27, 2026 – Borealis Foods Inc. (Nasdaq: BRLS) (the “Company”) today announced that on May 21, 2026, the Company received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to the Company's failure to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2026 (the “Q12026 Form 10-Q”) with the Securities and Exchange Commission (the “SEC”). The Notice supplements the prior notice received by the Company from Nasdaq on April 17, 2026 relating to the Company's delayed Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “2025 Form 10-K”), as previously disclosed. The Notice has no immediate effect on the listing or trading of the Company's Common Shares or Warrants on the Nasdaq Capital Market.

 

In accordance with Nasdaq's listing rules, the Company has until June 16, 2026 to submit a plan of compliance to Nasdaq addressing how the Company intends to regain compliance with the Listing Rule with respect to both the 2025 Form 10-K and Q12026 Form 10-Q. If Nasdaq accepts the Company's plan, Nasdaq may grant the Company up to 180 calendar days from the due date of the 2025 Form 10-K, or until October 12, 2026, to regain compliance. The Company intends to file the Q12026 Form 10-Q as soon as practicable, and currently expects to do so no later than early June 2026, which the Company believes, together with the filing of the 2025 Form 10-K, will cure the deficiency and regain compliance with the Listing Rule.

 

About Borealis Foods Inc.

 

Borealis Foods Inc. is a food technology company focused on developing and commercializing innovative, nutritious, and affordable food products. The Company's Common Shares and Warrants are listed on the Nasdaq Capital Market under the symbols “BRLS” and “BRLSW,” respectively. For more information, visit www.borealisfoods.com.

 

Forward-Looking Statements

 

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, but are not limited to, statements regarding the Company's anticipated timing for filing the Q12026 Form 10-Q and the Company's ability to regain compliance with Nasdaq's listing rules. Forward-looking statements are generally identified by words such as “anticipates,” “believes,” “expects,” “intends,” “plans,” “will” and similar expressions. These statements are based on the Company's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements, including risks related to the completion of the Company's interim financial statements and related interim review, the Company's ability to file the Q12026 Form 10-Q within the anticipated timeframe, the Company's ability to regain and maintain compliance with Nasdaq's continued listing requirements, and other risks and uncertainties described in the Company's filings with the Securities and Exchange Commission. The Company's filings with the SEC are available at www.sec.gov. Investors should not place undue reliance on the Company's forward-looking statements. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release, except as required by applicable law.

 

FAQ

Why did Borealis Foods (BRLS) receive a Nasdaq deficiency notice?

Borealis Foods received a Nasdaq deficiency notice because it failed to timely file its 2025 Form 10-K and Q1 2026 Form 10-Q with the SEC. This violates Nasdaq Listing Rule 5250(c)(1), which requires listed companies to submit all periodic reports on time.

Does the Nasdaq notice immediately affect trading of BRLS shares and warrants?

The Nasdaq notice has no immediate effect on trading of Borealis Foods’ common shares or warrants on the Nasdaq Capital Market. The company remains listed while it works to regain compliance by filing its delayed reports and submitting an acceptable compliance plan.

What deadlines has Nasdaq given Borealis Foods (BRLS) to regain compliance?

Borealis Foods has until June 16, 2026 to submit a plan explaining how it will regain compliance. If Nasdaq accepts that plan, the company may have until October 12, 2026, measured from the 2025 Form 10-K due date, to fully cure the filing deficiencies.

How does Borealis Foods plan to address its late SEC filings?

Borealis Foods states it intends to file its Q1 2026 Form 10-Q as soon as practicable, expecting to do so by early June 2026. It believes that filing this quarterly report, together with the delayed 2025 Form 10-K, will restore compliance with Nasdaq’s listing rule.

What listing rule is Borealis Foods currently violating with Nasdaq?

Borealis Foods is currently out of compliance with Nasdaq Listing Rule 5250(c)(1). That rule requires companies with securities listed on Nasdaq to file all required periodic reports, such as Form 10-K and Form 10-Q, with the SEC on a timely basis.

What risks does the Nasdaq deficiency notice pose for Borealis Foods investors?

The Nasdaq deficiency notice introduces risk related to Borealis Foods’ continued Nasdaq listing if it does not cure its late filings. While trading is unaffected for now, the company must submit a compliance plan and complete its 2025 Form 10-K and Q1 2026 Form 10-Q filings.

Filing Exhibits & Attachments

5 documents